Alain Algazi

Alain Algazi

University of California San Francisco - San Francisco / United States
Others
AD Scientific Index ID: 1876832
person_outline Alain Algazi's MOST POPULAR ARTICLES
1-) Safety and tumor responses with lambrolizumab (anti–PD-1) in melanomaO Hamid, C Robert, A Daud, FS Hodi, WJ Hwu, R Kefford, JD Wolchok, ...New England Journal of Medicine 369 (2), 134-144, 201338452013
2-) Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutationsKT Flaherty, JR Infante, A Daud, R Gonzalez, RF Kefford, J Sosman, ...New England Journal of Medicine 367 (18), 1694-1703, 201228732012
3-) Comprehensive characterization of cancer driver genes and mutationsMH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...Cell 173 (2), 371-385. e18, 201816582018
4-) Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...The Lancet 393 (10167), 156-167, 201915212019
5-) Combined nivolumab and ipilimumab in melanoma metastatic to the brainHA Tawbi, PA Forsyth, A Algazi, O Hamid, FS Hodi, SJ Moschos, ...New England Journal of Medicine 379 (8), 722-730, 201812932018